Lifeline Scientific (LSE:LSI) FCF Margin % : 3.12% (As of Jun. 2016)

View and export this data going back to . Start your Free Trial

What is Lifeline Scientific FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Lifeline Scientific's Free Cash Flow for the six months ended in Jun. 2016 was £0.40 Mil. Lifeline Scientific's Revenue for the six months ended in Jun. 2016 was £12.80 Mil. Therefore, Lifeline Scientific's FCF Margin % for the quarter that ended in Jun. 2016 was 3.12%.

As of today, Lifeline Scientific's current FCF Yield % is 7.38%.

The historical rank and industry rank for Lifeline Scientific's FCF Margin % or its related term are showing as below:

LSE:LSI' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 15.3
Current: 15.3

During the past 12 years, the highest FCF Margin % of Lifeline Scientific was 15.30%. The lowest was 0.00%. And the median was 0.00%.

LSE:LSI's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.525 vs LSE:LSI: 15.30

Lifeline Scientific FCF Margin % Historical Data

The historical data trend for Lifeline Scientific's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific FCF Margin % Chart

Lifeline Scientific Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

FCF Margin %

Get a 7-Day Free Trial

-6.99

-13.16

-7.56

-1.67

14.98

Lifeline Scientific Semi-Annual Data
	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16
FCF Margin %	Get a 7-Day Free Trial										-8.83	3.72	-1.07	24.88	3.12

Competitive Comparison of Lifeline Scientific's FCF Margin %

For the Medical Devices subindustry, Lifeline Scientific's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifeline Scientific's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Lifeline Scientific's FCF Margin % falls into.

Lifeline Scientific FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Lifeline Scientific's FCF Margin for the fiscal year that ended in Dec. 2015 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2015 )	/	Revenue (A: Dec. 2015 )
	=	3.942	/	26.31
	=	14.98 %

Lifeline Scientific's FCF Margin for the quarter that ended in Jun. 2016 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2016 )	/	Revenue (Q: Jun. 2016 )
	=	0.4	/	12.804
	=	3.12 %

Lifeline Scientific FCF Margin % Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifeline Scientific (LSE:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lifeline-scientific.com

Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.